首页> Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research> Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial

Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial

导出原文传递

翻译打印收藏纠错

第一作者： René Westhovens

作者： René Westhovens ^[1] ; William F C Rigby ^[2] ; Désirée van der Heijde ^[3] ; Daniel W T Ching ^[4] ; William Stohl ^[5] ; Jonathan Kay ^[6] ; Arvind Chopra ^[7] ; Beatrix Bartok ^[8] ; Franziska Matzkies ^[9] ; Zhaoyu Yin ^[10] ; Ying Guo ^[11] ; Chantal Tasset ^[12] ; John S Sundy ^[13] ; Angelika Jahreis ^[14] ; Neelufar Mozaffarian ; Osvaldo Daniel Messina ; Robert BM Landewé ; Tatsuya Atsumi ; Gerd R Burmester

作者单位： University of Southern California Keck School of Medicine ^[1] Department of Rheumatology ^[2] Geisel School of Medicine at Dartmouth ^[3] Division of Rheumatology, Department of Medicine ^[4] Ichnos Sciences ^[5] Gilead Sciences ^[6] Department of Rheumatology and Clinical Immunology ^[7] Centre for Rheumatic Diseases ^[8] Department of Development and Regeneration, Skeletal Biology and Engineering Research Center ^[9] Cosme Argerich Hospital ^[10] Department of Rheumatology, Endocrinology and Nephrology ^[11] Galapagos NV ^[12] Department of Rheumatology & Clinical Immunology ^[13] Timaru Medical Specialists Limited ^[14]

关键词 arthritis rheumatoid therapeutics antirheumatic agents

发布时间 2021-09-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交